Price T Rowe Associates Inc Relay Therapeutics, Inc. Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 6,879,597 shares of RLAY stock, worth $47.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,879,597
Previous 8,581,167
19.83%
Holding current value
$47.7 Million
Previous $94.5 Million
39.56%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding RLAY
# of Institutions
187Shares Held
127MCall Options Held
4.2KPut Options Held
1.7K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$194 Million2.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$82 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.8MShares$68 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY7.42MShares$51.5 Million4.98% of portfolio
-
State Street Corp Boston, MA6.02MShares$41.8 Million0.0% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $834M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...